TERT-BUTYL 4-METHYL-1H-PYRAZOLE-1-CARBOXYLATE, 95.0%, 5g

2,4-Dichlorobenzoic acid, 98.0%, 500g

[1-(4-fluorophenyl)ethyl]methylamine Hydrochloride, 95.0%, 1g

2,2-Difluorocyclohexan-1-amine hydrochloride, 95.0%, 1g

2,2-DIMETHYL-5-(2-QUINOLINYL)-1,3-DIOXANE-4,6-DIONE, 95.0%, 250mg

(1S,2S)-(+)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)cobalt(III) p-toluenesulfonate, 97%, 25g

3-METHYL-1-(TETRAHYDRO-2H-PYRAN-4-YL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE, 95.0%, 250mg

5'-Bromo-2'-hydroxypropiophenone>98.0%(GC)(T)5g

Tripropylene glycol monomethyl ether, min 97%, for synthesis, 2.5 l, plastic packaging.

tert-butyl 1-oxa-6-azaspiro[3.5]nonane-6-carboxylate, 98%, 100mg

3-Aminobutan-2-ol, 97%, 2.5g

2,5-DIOXOPYRROLIDIN-1-YL PENT-4-YNOATE, 95%, 1g

1-Propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-, 98%, 50mg